Spironolactone for Heart Failure with Preserved Ejection Fraction
Spironolactone for Heart Failure with Preserved Ejection Fraction
About this item
Full title
Author / Creator
Pitt, Bertram , Pfeffer, Marc A , Assmann, Susan F , Boineau, Robin , Anand, Inder S , Claggett, Brian , Clausell, Nadine , Desai, Akshay S , Diaz, Rafael , Fleg, Jerome L , Gordeev, Ivan , Harty, Brian , Heitner, John F , Kenwood, Christopher T , Lewis, Eldrin F , O'Meara, Eileen , Probstfield, Jeffrey L , Shaburishvili, Tamaz , Shah, Sanjiv J , Solomon, Scott D , Sweitzer, Nancy K , Yang, Song , McKinlay, Sonja M and TOPCAT Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this trial, 3445 patients with heart failure and a preserved ejection fraction were assigned to spironolactone or placebo. At a mean of 3.3 years, there was no significant difference in death from cardiovascular causes, aborted cardiac arrest, or hospitalization for heart failure.
Many patients with heart failure have a normal or near-normal...
Alternative Titles
Full title
Spironolactone for Heart Failure with Preserved Ejection Fraction
Authors, Artists and Contributors
Author / Creator
Pfeffer, Marc A
Assmann, Susan F
Boineau, Robin
Anand, Inder S
Claggett, Brian
Clausell, Nadine
Desai, Akshay S
Diaz, Rafael
Fleg, Jerome L
Gordeev, Ivan
Harty, Brian
Heitner, John F
Kenwood, Christopher T
Lewis, Eldrin F
O'Meara, Eileen
Probstfield, Jeffrey L
Shaburishvili, Tamaz
Shah, Sanjiv J
Solomon, Scott D
Sweitzer, Nancy K
Yang, Song
McKinlay, Sonja M
TOPCAT Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1515646288
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1515646288
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1313731
